If you have been on a stable dose and suddenly notice your appetite returning stronger than usual, storage-related potency loss could be the cause
A 62-year-old woman with chronic health problems since the age of 10, who experienced anaphylactic attacks, fatigue, tinnitus, bone pain, itching, and nausea, and was largely housebound, tried semaglutide at 0.125 mg once a week
The article rates COX-2 inhibitors as moderate risk: lower gastrointestinal risk than traditional NSAIDs because they are selective for COX-2, but still requiring caution and provider approval alongside semaglutide
#SunPharma #Semaglutide #GenericDrugs #Pharmaceuticals #Healthcare #Type2Diabetes #DiabetesCare #SouthAfrica #SAHPRA #DrugApproval #PharmaNews #PharmaIndustry #PharmaInnovation #GenericMedicines #AffordableHealthcare #PatientAccess #HealthcareInnovation #LifeSciences #Biopharma #GlobalHealthcare Sun Pharma launches generic semaglutide in South Africa Sun Pharmas approval to launch generic semaglutide in South Africa marks another step toward improving treatment accessibility
Rather than functioning as a transactional service, the program emphasizes continuity and accountability across the treatment lifecycle